Viewing Study NCT00329693


Ignite Creation Date: 2025-12-25 @ 1:13 AM
Ignite Modification Date: 2026-02-01 @ 1:12 AM
Study NCT ID: NCT00329693
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2006-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide
Sponsor: Ferring Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Hyperstimulation Syndrome View
Keywords: